Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An update from Immuron Limited ( (AU:IMC) ) is now available.
Immuron Limited has announced the issuance of 1,133,840 ordinary shares without disclosure under Part 6D.2 of the Corporations Act. The company confirms compliance with relevant provisions of the Corporations Act and states there is no excluded information requiring disclosure, indicating a transparent operational stance.
More about Immuron Limited
Immuron Limited operates in the biotechnology industry, focusing on the development and commercialization of oral immunotherapy products for the treatment of gut-mediated diseases.
YTD Price Performance: 1.27%
Average Trading Volume: 203,461
Technical Sentiment Signal: Hold
Current Market Cap: A$21.46M
Find detailed analytics on IMC stock on TipRanks’ Stock Analysis page.